Healing Joints

Revolutionizing osteoarthritis therapy by developing best-in-class epigenetic orthobiologics.

Our targets

Military Research

Collaborations focused on enhancing the resilience of soldiers’ joints after traumatic injury, stabilizing joints molecular response post-injury, and reducing the likelihood of progression to post-traumatic osteoarthritis (PTOA).

Primary Osteoarthritis

Advanced intraarticular biologics designed to slow or reverse cartilage damage caused by osteoarthritis (OA).

Veterinary Care

Targeted treatments to improve mobility in companion and working animals with osteoarthritis.

Learn more

Our Team

Matlock Jeffries MD FACP FACR

Founder

As a physician-scientist, Dr. Jeffries has led pioneering efforts into understanding how epigenetic changes are associated with OA onset and progression. His expertise bridges cutting-edge gene therapy research and practical clinical trials.

Contact Us

Interested in working together? Fill out some info and we will be in touch shortly. We can’t wait to hear from you!